- With Mayo Clinic endocrinologist
Maria Collazo-Clavell, M.D.
read biographyclose windowBiography of
Maria Collazo-Clavell, M.D.
Maria Collazo-Clavell, M.D.
Dr. Maria Collazo-Clavell is board certified in internal medicine, endocrinology, diabetes and metabolism. She is a consultant in the Division of Endocrinology, Diabetes, Metabolism & Nutrition at Mayo Clinic and an assistant professor at Mayo Clinic College of Medicine.
The Aibonito, Puerto Rico, native has been with Mayo Clinic since 1994.
She is a member of the American Association of Clinical Endocrinologists, the American College of Endocrinology, the American Diabetes Association and The Endocrine Society.
Dr. Collazo-Clavell is medical editor for the Web site's diabetes content and the book "Mayo Clinic on Managing Diabetes." Her clinical interests include management of type 1 and type 2 diabetes, obesity and nutritional disorders.
More answers
- Carbohydrate counting and diabetes: Looking beyond carbs
- Diabetes management: Does aspirin therapy prevent heart problems?
- Diabetes: Are electric blankets off-limits?
- Late-night eating: OK if you have diabetes?
- Diabetes foods: Is honey a good substitute for sugar?
- Reactive hypoglycemia: What causes it?
- Diabetes treatment: Can cinnamon lower blood sugar?
- Artificial sweeteners: Any effect on blood sugar?
- Blood sugar and mood: Any connection?
- Vegetarian diet: Can it help me control my diabetes?
- Glycemic-index diet: A helpful tool for diabetes?
- Diamaxol: An herbal cure for diabetes?
- The 'dawn phenomenon': What causes it?
- Diabetes: How does it affect my liver?
- Diabetes diet: Should I avoid sweet fruits?
- see all
Mayo Clinic Health Manager
Get free personalized health guidance for you and your family.
Get Started
Mayo Clinic Housecall
Stay up to date on the latest health information.
What you get
- Free weekly e-newsletter
- Mayo Clinic expertise
- Recipes, tools and other helpful information
- We do not share your e-mail address
Question
Diabulimia: How are diabetes and eating disorders related?
What can you tell me about diabulimia? Who is at risk? And what are the consequences?
Answer
from Maria Collazo-Clavell, M.D.
Insulin therapy is the cornerstone of any treatment plan for type 1 diabetes. Skipping or shortchanging doses of insulin to prevent weight gain — a common side effect of insulin therapy — is a dangerous practice sometimes referred to as diabulimia. Although diabulimia can affect anyone who has type 1 diabetes, adolescent girls are most likely to manipulate insulin doses to lose weight. In fact, according to the American Diabetes Association, an estimated 30 percent to 40 percent of female teens and young adults who have diabetes skip or alter insulin doses to control their weight.
Diabulimia isn't a recognized medical condition. In fact, the term has only gained popularity recently. But like all eating disorders, diabulimia has serious consequences.
People who have type 1 diabetes need insulin therapy to survive. Without enough insulin, sugar (glucose) can't enter the cells. This causes the person's blood sugar level to rise. Eventually, insufficient insulin can lead to diabetic ketoacidosis — a life-threatening condition in which the body breaks down fat and protein for energy. High blood sugar also increases the risk of long-term diabetes complications, including heart and blood vessel disease, nerve damage and kidney damage.
Warning signs of diabulimia may include:
- Weight loss
- Excessive thirst
- Frequent urination
- Low energy
- Nausea
- Fruity-scented breath (a sign of diabetic ketoacidosis)
- Decreased attention to blood sugar monitoring or insulin doses
- Loss of blood sugar control
Often, diabulimia is suspected by a friend or parent before the person who has diabetes admits that anything is wrong. If you have diabulimia or you suspect that a loved one has diabulimia, seek help immediately. Ideally, treatment will involve specialists in both eating disorders and diabetes. Early intervention may save a life.
Next question
